Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMNL - iMedia International Releases Results of 2005 Operations Net Revenues Increase 159 Percent to $5.9 Million -- Gross Profits Improve Significantly
Thursday April 20, 9:00 am ET
Company Prepares for Aggressive Growth in 2006
SANTA MONICA, Calif., April 20, 2006 (PRIMEZONE) -- iMedia International, Inc. (OTC BB:IMNL.OB - News) (http://www.imedia-intl.com) released its results of operations for the year ended December 31, 2005. The Company saw a dramatic increase in net sales to $5.93 Million, an increase of $3.64 million or 159% over the comparable 2004 period.
In addition, the Company showed a significant improvement in gross profitability with an increase from a negative gross loss of $252,000 to $900,000 in gross profit. This represents an increase of $1.12 million over the comparable 2004 period. The improvement was a direct result of their increased sales to a larger and developing client base. According to the Company, they continue to contract custom interactive media projects with both new and repeat customers. Most importantly, gross margin rates on these projects are now more typical of their targeted, future anticipated margins.
``We considered 2004 and 2005 as an important start-up period where we concentrated mainly on developing our customer acquisition programs and refining our pilot programs,'' said Kevin Plate, EVP of Sales and Business Development. ``We realized that in order to attract new customers to our new media, we often had to price our initial pilot programs below actual costs. Since we now have several years of success, we have been able to adjust our pricing accordingly.''
``We are thrilled to see the continuing escalation in our sales and gross profitability,'' said David MacEachern, CEO of iMedia International. ``It is important to understand that this growth reflects only the expansion of our custom solution business which we concentrated on during 2004 and 2005. When we factor in the launch of our newspaper syndication program which is beginning later this month, and our plans for a national newspaper rollout during 2006 and 2007, I am very confident that this aggressive growth will be sustained.''
Total operating expenses increased $5.25 million to $8.97 million for the year ended December 31, 2005 a 141% increase over the comparable 2004 period. The increase is primarily attributable to an increase in selling expenses of $1.7 million or 152%, and an increase in general and Administrative expenses of $3.6 million or 166%. This compares to $6.2 million in the comparable 2004 period.
The Company attributes the increase in selling expenses directly to the increase from three to eight full-time sales executives, and their related travel and entertainment costs. Also, the Company was required to continue underwriting revenue shortfalls for its Hollywood Previews Entertainment iMagazine while they prepared to launch their national newspaper syndication rollout. This national rollout is scheduled to begin on April 30, 2006 at which time subsidizes should decrease as the program begins to generate new revenues.
Increases in the Company's General and Administrative expenses were primarily due to an increase in professional fees associated with its various financings during 2005. These included approximately $3.2 million in non-cash expenses, as opposed to approximately $44,000 for the comparable period in 2004. The majority of these non-cash expenses were related to non-recurring costs associated with the issuance of common stock and warrants to prior investors, investment bankers, to advisors and consultants, and for promotion of its ongoing financing activities.
``We are very pleased to see the increased acceptance of our convergent media in the marketplace and look forward to continued top-line growth during the second half of 2006 as our newspaper syndication program comes on line,'' said Anthony Fidaleo, CFO. ``Despite these milestones however, we are disappointed in the impact that the costs of financing has had on our financial statements as well as our operations. We look forward to the national adoption of our newspaper syndication business, and we believe that our revenue growth will begin to offset our cash burn over the next several quarters.''
During the period, the Company recorded a $12.2 million net loss, which includes $4.1 million in non-cash other expense items. These non-cash items were primarily related to the costs associated with the issuances of preferred stock and the write-down of certain investments during the year ended December 31, 2005. The increase in non-cash other expenses totaled $3.23 million for a 345% increase over the comparable 2004 period.
On September 28, 2005, the Company filed a registration statement on Form SB-2, which has not yet been declared effective. The Company is still responding to comments from the Securities and Exchange Commission and is required to amend its registration statement to include its financial statements for the period ending December 31, 2005. The Company anticipates that it will have its registration statement amended and respond to the SEC's comments around May 1, 2006.
About iMedia International, Inc.
iMedia International, Inc. (IMNL) is a publicly held digital media solutions company producing DVD's, and CD-ROM's for digital multimedia marketing and promotional campaigns. iMedia publishes proprietary and custom digital iMagazines and offers expert digital media solutions services including: strategic planning, content aggregation and production, disc audio/video design, authoring, editing and compression, disc packaging manufacturing and distribution. A key feature of iMedia's technology is its iReporting(tm) real-time, online tracking system which provides quantitative data on disc viewer usage patterns and effectiveness of iMedia marketing and promotional campaigns.
For more information on iMedia International, Inc. please contact:
Kelly R. Konzelman, Executive Vice President
1721 21st Street, Santa Monica, CA 90404
Phone: (310) 453-4499
Fax: (310) 453-6120
kellyk@imedia-intl.com
The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements about the Company's future financial performance, and the increase in sales and top-line revenue growth. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectations or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, product development and acceptance, the impact of competitive services and pricing, general economic risks and uncertainties, and various other information detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date thereof. The forward-looking statements contained in this release should not be relied upon for the basis of any investment decisions. The Company faces other risks that are not contained in this disclosure. Investors should refer to the full filing of the Company's Annual Report on Form 10-KSB dated April 19, 2006 at http://www.sec.gov, before making an investment decision.
IMEDIA INTERNATIONAL, INC.
COMBINED BALANCE SHEETS
DECEMBER 31, 2005 AND DECEMBER 31, 2004
December 31, December 31,
2005 2004
(Restated)
------------- ------------
Assets
Current assets:
Cash $ 1,397,904 $ 453,304
Accounts receivable,
net of allowance
for doubtful accounts
of $25,000 and $0 1,820,483 46,444
Work in process 27,779 --
Prepaid expense 13,5621 554
----------- -----------
Total current assets 3,259,727 500,302
Property and equipment, net 140,486 78,211
Investment in available
for sale securities -- 1,066,461
----------- -----------
Total assets $ 3,400,213 $ 1,644,974
ViroPharma Announces Approval of Third Party Manufacturing and Supply Chain for Vancocin
PR Newswire - April 19, 2006 16:30
EXTON, Pa., April 19, 2006 /PRNewswire-FirstCall via COMTEX/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced the successful completion of the finished goods technology transfer from Eli Lilly and Company to OSG Norwich Pharmaceuticals, Inc., the company's third party Vancocin(R) manufacturer. Norwich has begun manufacturing batches of product for release into the market. ViroPharma has also reached an agreement with, and validated, Alpharma Inc., the company's third party supplier of the active pharmaceutical ingredient for Vancocin. With this, the company has now completed validation of its third party supply chain for Vancocin, which is indicated for the treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile.
"This is a great step forward for ViroPharma and the patients we serve," commented Josh Tarnoff, ViroPharma's Chief Commercial Officer. "Vancocin is a product that addresses a life-threatening condition, and is a difficult product to manufacture to necessary specifications to ensure stability and potency. The validation of the supply chain represents the successful conclusion of nearly two years of diligent work by ViroPharma, Eli Lilly and Norwich."
As previously described, ViroPharma anticipates improvements in gross margins, due to the qualification of this third party supply chain, beginning in the second half of 2006, as product manufactured in the Lilly facility is pulled through the channel.
C. difficile is a bacterium, which under certain circumstances, typically after antibiotic therapy, can colonize the lower gastrointestinal tract where it may produce toxins which cause inflammation of the colon and diarrhea, and the associated complications of disease, including death. Advanced age, gastrointestinal surgery/manipulation, long length of stay in healthcare settings, a serious underlying illness and compromised immunity are conditions associated with increased risk of disease. According to the CDC, there are approximately 3,000,000 cases of antibiotic-associated diarrhea per year; 15 to 25 percent are caused by C. difficile.
ARTX here comes .50 The entire float was traded in the last 6 days.
I saw that '-0 i sold all my PTSC and put half in ARTX .I'm up 10% i think i made the right move as ARTX will gain more % .IMO
PS ARTX .47 It will blow here.
ARTX .46
EUSI - Eugene Science Receives Order From Amway - Korea for Its CholFree(TM) Cooking Oil
Wednesday April 19, 8:00 am ET
LOS ANGELES, CA--(MARKET WIRE)--Apr 19, 2006 -- Eugene Science, Inc. (OTC BB:EUSI.OB - News), a developer and marketer of advanced nutraceutical products, today announced that Amway - Korea has placed an order for its CholFree(TM) cholesterol-lowering cooking oil. Amway - Korea, Ltd. is the Korean subsidiary of Ada, Michigan-based Amway, the global leader in multi-level consumer product marketing.
Eugene Science is the sole cooking oil supplier to Amway - Korea, supplying its CholFree(TM) cholesterol absorption-blocking premium cooking oil since 2003. CholFree(TM) cooking oil has been ranked in the top ten for sales and customer loyalty among local food products distributed by Amway - Korea.
"CholFree is the original cholesterol-lowering product we first introduced three years ago, and are pleased to see it now opening the market for healthy, premium cooking oils," said Mr. Seung Kwon Noh, Chief Executive Officer, Eugene Science. "Amway - Korea has been a strong distributor and marketing partner, and we appreciate their confidence in CholFree's future."
The market for premium cooking oils is rapidly growing, boosted by recent explosive sales growth of premium olive oils as health conscious consumers seek cooking oils with healthier properties and nutraceutically active ingredients. Industry analysts report the South Korean cooking oil market continues to grow, with its 2005 revenues estimated at $667 million.
CholFree(TM) oil is an edible healthy corn oil, which contains natural plant sterols helping to maintain healthy cholesterol levels in the body by inhibiting cholesterol absorption. As part of healthy diet and exercise regimen, this product is designed to help reduce the total cholesterol level, especially LDL (the "bad") cholesterol, and reduce the risk of heart disease. CholFree(TM) cooking oil has won strong support from health-conscious consumers and is serving to create a new market for premium cooking oils in Korea. These plant sterols have been shown in clinical studies to lower cholesterol and are approved by the United States Food and Drug Administration (FDA) for health claims related to their cholesterol-lowering efficacy.
MSEV - Micron Looking Into Additional Alberta Oil Sands Ventures
Wednesday April 19, 8:00 am ET
VANCOUVER, British Columbia, April 19, 2006 (PRIMEZONE) -- Micron Enviro Systems, Inc. (OTC BB:MSEV.OB - News) (Frankfurt:NDD.F - News) (``Micron'') wishes to announce it is currently looking into expanding its exposure to the Alberta Oil Sands. These possible new ventures include new Oil Sands partnerships and/or new Oil Sands leases.
Micron has just added three new Alberta Oil Sands leases consisting of 4 new sections in the world-class Athabasca Oil Sands region. Two of these new sections are within 5 miles of Micron's existing Athabasca Oil Sands Prospect. These two new sections are close to the existing Oil Sands leases held by Connacher Oil and Gas's Great Divide Prospect, as well as to other major Oil Sands projects by Devon, Encana, and Cononco Philips.
The other new Alberta Oil Sands lease acquired consists of two contiguous sections that lie just southwest of the announced Royal Dutch Shell Plc Oil Sands leases which they recently purchased for approximately $400 million.
The Oil Sands of Canada hold recoverable reserves of 175 billion barrels with a proven reserve life of 480 years and another 130 billion barrels of potential reserves, which is second only to Saudi Arabia's 262 billion barrels. As a comparison, the United States has only 29 billion barrels of recoverable reserves and has decreasing domestic production while their demand is increasing by 1-2% every year. Canada is in an optimal position to supply oil to the U.S. with its favorable political climate, close proximity and being one of the few non-OPEC countries which can grow its oil production.
Bernie McDougall, President of Micron stated, ``Now that we are participating in four Alberta Oil Sands leases, we have a firm understanding of how to acquire additional prospects and have clearly shown our ability to accomplish our goals of acquiring new leases. We are attempting to build our shareholder value through new acquisitions, as well as development of our existing Alberta Oil Sands leases, complemented by our conventional drilling projects. We are anticipating a significant increase in ownership interest in any additional Oil Sands prospects as this is what we feel will drive our company's future value. When you consider that oil prices are at all time highs, clearly these are exciting times for Micron and Micron's shareholders.''
Micron is an emerging oil and gas company that has exposure to four separate leases in the Athabasca Oil Sands of Alberta, Canada, which is the largest Oil Sands region in the world, and has production from multiple conventional oil and gas wells. Micron is one of if not the smallest market capitalized companies with exposure to multiple Alberta Oil Sands. Micron's goal is to become a junior oil and gas producer that focuses on the exploration, discovery and delivery of gas and oil to the North American marketplace. Micron currently has multiple independent sources of oil and/or gas revenue from production in Canada and Texas. Micron is presently involved in multiple oil and gas prospects, and continues to look for additional projects that would contribute to building Micron's market capitalization, including additional Oil Sands projects.
DOC - Digital Angel's Cattle Tag Sales in Argentina Now Exceed 1.4 Million for 2006
Wednesday April 19, 7:30 am ET
Recent Order of 160,000 Cattle Tags Continues to Expand DA's Market Share in South America
SO. ST. PAUL, Minn., April 19 /PRNewswire-FirstCall/ -- Digital Angel Corporation (Amex: DOC - News), an advanced technology company in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets, announced today that it has received a new order for 160,000 cattle tags, raising 2006 orders to over 1.44 million cattle tags in Argentina. The company has now exceeded by over 30 percent the total of 1.1 million orders for the entire year of 2005.
Digital Angel President and Chief Executive Officer Kevin McGrath said this new order combined with the approval of our visual and electronic tags in Chile is certainly good news and shows our increased penetration of the South American Markets. The rapidly expanding orders demonstrate that the Company is becoming a significant presence in Argentina, one of the most important cattle markets in the world with an estimated 55 million head of cattle throughout the country and is expanding on this strength in other countries in South America.
"I am very enthusiastic with the success of our Argentine operation, specifically that we have exceeded our entire 2005 output by over 30 percent in just the first three and a half months of 2006," McGrath said. "We will continue to focus on making Argentina a very strong and growing market as well as expanding into new markets in South America. Our top-notch team and their strong distribution network and excellent customer service is expanding our sales base at a tremendous pace."
About Digital Angel Corporation
Digital Angel Corporation develops and deploys sensor and communications technologies that enable rapid and accurate identification, location tracking, and condition monitoring of high-value assets. Applications for the Company's products include identification and monitoring of humans, pets, fish, poultry and livestock through its patented implantable microchips; location tracking and message monitoring of vehicles and aircraft in remote locations through systems that integrate GPS and geosynchronous satellite communications; and monitoring of asset conditions such as temperature and movement, through advanced miniature sensors.
Digital Angel Corporation is majority-owned by Applied Digital Inc. (Nasdaq: ADSX - News). For more information about Digital Angel, please visit www.DigitalAngelCorp.com.
RMTI - Rockwell Medical Technologies, Inc. Receives European Patent Issuance for Proprietary Iron-Delivery Technology
Wednesday April 19, 8:00 am ET
WIXOM, Mich., April 19 /PRNewswire-FirstCall/ -- Rockwell Medical Technologies, Inc. (Nasdaq: RMTI - News), a leading, innovative hemodialysis products manufacturer in the healthcare industry, reported that the European Patent and Trademark Office has issued a patent for Rockwell's proprietary iron-delivery product SFP, which covers the "Method and Pharmaceutical Composition for Iron Delivery in Hemodialysis and Peritoneal Dialysis Patients." Rockwell reported on August 10, 2005 that the EPTO had allowed its claims for the proprietary drug/device.
Rockwell's proprietary product SFP is designed to provide physiological iron replacement in ESRD patients by delivering iron via dialysate during hemodialysis and peritoneal dialysis treatment. Rockwell has licensed the exclusive rights to the SFP patent and is in the process of seeking FDA approval to market the product.
The countries the patent grant will affect are Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland and the United Kingdom.
Compared to intravenous (IV) iron administration, results based on an FDA approved Phase II Study have shown that delivering iron via dialysate is a safer and more effective method for maintaining iron balance in dialysis patients, while at the same time eliminating associated nursing and pharmaceutical IV iron administration costs. Rockwell estimates that the U.S. dialysis market for IV iron delivery represents $450 million annually while the global market potential is approximately $750 million annually. Upon FDA market approval, Rockwell expects SFP to compete aggressively for those markets. Visit Rockwell's website at http://www.rockwellmed.com/ironnews.htm for more information on SFP.
Mr. Robert L. Chioini, Chairman, CEO and President of Rockwell stated, "This European patent issuance was expected based on the allowance we had previously received. It is a significant step for Rockwell as it enables us to protect our proprietary technology in a major market. Currently, we are making solid progress in our FDA development process and we expect to achieve several more significant milestones as we work towards market approval."
UGHO - Universal Guardian Delivers Record Revenues of $14 Million for FY 2005
Wednesday April 19, 8:00 am ET
NEWPORT BEACH, Calif., April 19 /PRNewswire-FirstCall/ -- Universal Guardian Holdings, Inc. (OTC Bulletin Board: UGHO - News), an emerging global leader in inter-modal transportation security, global supply chain RFID systems, tactical products and security services to protect against business against criminal, terrorist, and security threats, today announced that it has delivered record financial performance with revenues of $14 million for FY2005.
"Our 2005 financial projections have proven to have been accurate," stated Michael Skellern, CEO of Universal Guardian. "With $19 million in signed contracts in-hand by Q1 2006 and the introduction of our new non-lethal products and ground-breaking and proprietary RFID based asset identification, authentication and monitoring systems and related technologies, we expect to meet or exceed our public announced revenue projections of $35 Million for FY2006. We also expect to make further guidance announcements regarding revenue increases, positive cash flow and year-end profitability by midyear 2006," continued Mr. Skellern.
About Universal Guardian Holdings, Inc.
ITEC - Itec Environmental Group, Inc. Signs Letter of Intent with Waste Management Recycle America, L.L.C. to Acquire Two Plastic Recycling Facilities
Wednesday April 19, 8:30 am ET
OAKDALE, Calif., April 19, 2006 (PRIMEZONE) -- Itec Environmental Group, Inc., a Delaware corporation (``Itec'), (OTC BB:ITEC.OB - News) has completed the execution of a Letter of Intent with Waste Management Recycle America, L.L.C. (``WMRA'), a wholly owned subsidiary of Waste Management, Inc. (NYSE:WMI - News) (the ``LOI'), to acquire two plastic recycling facilities located in the Chicago, Illinois and Raleigh, North Carolina (the ``Acquisitions').
The contemplated acquisitions of the two WMRA facilities (the ``Facilities') will enable Itec to: (i) secure a long-term commercially significant supply of plastic, and (ii) integrate its proprietary Eco2(tm) Environmental System (the ``Eco2 Environmental System') into the Facilities, thereby making the Facilities more profitable.
In connection with the Acquisitions, Itec and WMRA intend to enter in a long term agreement, which shall provide for the steady supply of mixed plastics to Itec's newly acquired facilities by WMRA through the network of WMRA recycling facilities throughout the United States.
Both parties to the LOI are engaged in the due diligence process. In the event the acquisitions are consummated, Itec expects the acquisitions to be completed on or by June 30, 2006.
``We believe these potential acquisitions will bring tremendous value to both Itec and its shareholders by securing a substantial long-term supply of PET, and HDPE, and by allowing Itec to build-out additional facilities which utilize our Eco2 Environmental System. These anticipated acquisitions of the Waste Management Recycle America facilities not only accelerate our business plan and allow us to implement our Eco2 Environmental System in established plastic recycling facilities, but also enable us to do so with a more efficient and fiscally sound plastic recycling technology,' stated Gary DeLaurentiis, Chief Executive Officer of Itec.
About the Company
Itec Environmental Group offers solutions to environmental problems faced by public agencies and private entities involved in the recycling of plastics. In a research partnership with Honeywell FM&T, Itec has developed and successfully commercialized a new system for the recycling of plastic containers. Its proprietary Eco2(tm) System costs thirty percent (30%) less to operate, uses no water, removes all contaminates and odors from the finished flake, is closed-loop and thus non-polluting, and produces no toxic by-products.
Please visit our web site at http://www.iteceg.com. Any interested parties wishing to be included in Itec Environmental Group's mailing list, please email your request to info@iteceg.com or Contact: Gary M. DeLaurentiis at 209-863-8076.
Cautionary Warning Regarding Forward-Looking Statements
This press release may contain ``forward-looking statements.' In some cases, you can identify forward-looking statements by terminology such as ``may,' ``will,' ``should,' ``could,' ``expects,' ``plans,' ``intends,' ``anticipates,' ``believes,' ``estimates,' ``predicts,' ``potential' or ``continue' or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results. Additional factors that could materially affect these forward-looking statements and/or predictions include, among other things: (1) our limited operating history; (2) our ability to pay down existing debt; (3) our ability to attract and retain key executive officers and the professional advisors necessary to guide us through our corporate restructuring; (4) unforeseen costs and expenses; (5) potential litigation with our shareholders, creditors and/or former or current investors; (6) the Company's ability to comply with federal, state and local government regulations; (7) the Company's ability to secure raw plastic, and produce and sell a large quantity of its PET and HDPE flake; and (8) other factors over which we have little or no control.
NNVC - NanoViricides, Inc. Retires 833,600 Shares
Wednesday April 19, 1:10 am ET
Company Finalizes Agreement Regarding Return of Unauthorized Stock and Cancellation of Options
NEW HAVEN, Conn.--(BUSINESS WIRE)--April 19, 2006--NanoViricides, Inc. (NNVC.PK), a biopharmaceutical company specializing in unique antiviral treatments that utilize its patented nanomicelle, today announced several first-quarter updates.
CEO Eugene Seymour, MD MPH, announced today that he has signed an agreement with the owners of the original shell company regarding their unauthorized issuance of stock during the transfer process. The original shell owners have agreed to return to the Company their unauthorized 833,600 shares for immediate cancellation. In addition, they agreed to cancellation of 700,000 of their options.
"The fact that the dispute is finally settled," stated Dr. Seymour, "means that we can now ready the company for its move to another exchange."
The agreement enables NanoViricides, Inc. to proceed with the previously planned financial audit and subsequent submission to the SEC. Once NanoViricides, Inc. becomes a reporting company it can then apply for a move to the Bulletin Board (OTCBB) exchange. The Company will then be eligible to apply to the NASDAQ when NASDAQ's financial and stock price requirements have been met.
re ARTX B/A .45 /.4491 weird
ARTX -How often have you guys seen ASks constanly below Bids and trades with 4 decimals went above ASKS or below Bids ?This has been going on for the last 5 days with over 72 MM shares traded.
VRDM dwn 14%
ARTX vol is exploding .The conversion is about done.IMO
VRDM I think it ran out of gas just like INSQ GSHF.The hype can only carry it so far but then again it 'not the first time i make a bad call,lol.
VRDM- i don't think u will see .32 today i think it will close in the red.IMHO
VRDM Good call guys .
ARTX is ready to blow..watch it .IMO
PYDS- No vol
I added more ARTX here .I think the debt conversion is about over and looking for at least 30% gain from here.GL & TY
PTSC- i'm out with 22K profit and will reload under .80 again.
VRDM I'm not touching that until in the low teen.GL
PTSC .87/.88 still have all my shares up 22% so far
Burst.com Files Patent Infringement Suit Against Apple Computer
Monday April 17, 5:10 pm ET
Announces Expansion of Legal Team
SANTA ROSA, CA--(MARKET WIRE)--Apr 17, 2006 -- Burst.com, Inc. (Other OTC:BRST.PK - News) today announced that it has filed counterclaims accusing Apple Computer of infringing four of Burst's U.S. patents. In the counterclaims, filed in Federal District Court in San Francisco on Monday, April 17th, Burst alleges that Apple's iTunes Music Store, iTunes software, the iPod devices, and Apple's QuickTime Streaming products infringe Burst's U.S. Patents 4,963,995; 5,995,705; 5,057,932 and 5,164,839. Burst's filing responds to a suit that Apple filed against Burst in January of this year, seeking a declaration that Burst's patents are invalid and that Apple does not infringe them. Burst requests in its counterclaims that Apple pay a reasonable royalty for Apple's infringing products and services, and also seeks an injunction against further infringement. A copy of the filing can be found on Burst's website:
DJ American Oriental Bioengineering, Inc. Announces Acquisition Of Guangxi Lingfeng Pharmaceutical Co (GLP); Acquisition Expands Pdt Line, Distribution Channels; Adds Complimentary Products In Women's Health Area>AOB
04/18/2006
Dow Jones News Services
(Copyright © 2006 Dow Jones & Company, Inc.)
(MORE TO FOLLOW) Dow Jones Newswires
04-18-06 0700ET
Copyright (c) 2006 Dow Jones & Company, Inc.
*DJ Amer Oriental Bioengineering Deal Is For $25M In Cash, Stk
Digital Angel's Visual, Electronic Livestock Tags Approved for Sale in Chile
PR Newswire - April 18, 2006 07:31
Tags Manufactured at European Subsidiary Now Registered in Chile as Official Identification Devices
SO. ST. PAUL, Minn., April 18, 2006 /PRNewswire-FirstCall via COMTEX/ -- Digital Angel Corporation (Amex: DOC), an advanced technology company in the field of rapid and accurate identification, location tracking, and condition monitoring of high-value assets, announced today that both its visual and electronic RFID (radiofrequency identification) livestock tags have now been approved for sale in Chile.
President and Chief Executive Officer Kevin N. McGrath stated: "Chile is an important part of our overall strategy of expanding our business in Latin America and we will be launching a strong push with both visual and electronic RFID tags to gain a significant share of this growing market. Chile and other parts of South America such as Argentina, Brazil and Uruguay have joined the European Union, Japan and the United States in recognizing the value of traceable beef. We are excited about this opportunity to expand our operations in the southern cone of South America and believe Chile will become an important market for us."
The approval of Digital Angel's visual Snaptag and electronic Digitag with FDX-B radio frequency technology was granted earlier this month in decree No. 1629 issued by the Chilean Agricultural and Cattle Service agency (Servicio Agricola y Ganadero de Chile). The tags, which are manufactured by the Company's Daploma subsidiary in Denmark, are now registered in Chile as Official Individual Identification Devices (DIIOs), a mandatory requirement in the Chilean cattle registration system.
Since launching its business in Chile in mid-2005, Digital Angel has sold to date more than 35,000 electronic tags in that country and over the same period it has sold or received firm orders for approximately 2.4 million livestock tags in Argentina and 44,000 tags in Uruguay.
Point Therapeutics to Present Novel Dual Mechanism of Action for Talabostat During Research and Development Day on April 25; Newly Identified Targets will be Unveiled
Business Wire - April 18, 2006 08:22
BOSTON, Apr 18, 2006 (BUSINESS WIRE) -- Point Therapeutics, Inc. (NASDAQ:POTP) announced it will comprehensively review the novel dual mechanism of action for its lead compound, talabostat, a targeted anti-cancer therapy. For the first time, Point will unveil the identified targets and cellular biochemistry responsible for talabostat's anti-tumor activity. The dual mechanism of action is based talabostat's inhibition of fibroblast activation protein (FAP) inhibition and talabostat's immunostimulatory properties. The R&D Day will be at the Four Seasons New York on April 25, 2006 from 4:30 to 6:30 pm ET.
The event will feature a scientific overview of talabostat by Dr. Barry Jones, Chief Scientific Officer at Point Therapeutics, and Dr. Charles Dinarello, Professor of Medicine, University of Colorado School of Medicine, who will review the peer-reviewed data available about the compound and its mechanism of action.
"We are pleased to have an opportunity to comprehensively present talabostat's mechanism of action during our upcoming R&D Day. Our extensive preclinical studies support an exciting, novel dual mechanism of action for talabostat. These studies are the foundation of talabostat's clinical program, which includes two Phase 3 studies in non-small cell lung cancer and ongoing Phase 2 studies in metastatic melanoma, chronic lymphocytic leukemia and pancreatic cancer," said Don Kiepert, President and CEO of Point Therapeutics.
For reservations, please contact Sarah Cavanaugh at 617-933-7508 or scavanaugh@pther.com.
About Point Therapeutics, Inc.:
Point is a Boston-based biopharmaceutical company developing a portfolio of dipeptidyl peptidase (DPP) inhibitors for use in cancer, type 2 diabetes and as vaccine adjuvants. Point is currently studying its lead product candidate, talabostat, in two Phase 3 trials in non-small cell lung cancer. Point is also studying talabostat in several Phase 2 trials, including as a single-agent in metastatic melanoma, in combination with cisplatin in metastatic melanoma, in combination with rituximab in advanced chronic lymphocytic leukemia, and in combination with gemcitabine in metastatic pancreatic cancer. In addition, Point's portfolio includes two other DPP inhibitors in preclinical development--PT-630 for type 2 diabetes, and PT-510 as a vaccine adjuvant.
Certain statements contained herein are not strictly historical and are "forward looking" statements as defined in the Private Securities Litigation Reform Act of 1995. This information includes statements with respect to the company's clinical development programs and the timing of initiation and completion of its clinical trials. Forward-looking statements are statements that are not historical facts, and can be identified by, among other things, the use of forward-looking language, such as "believes," "feels," "expects," "may," "will," "should," "seeks," "plans," "schedule to," "anticipates" or "intends" or the negative of those terms, or other variations of those terms of comparable language, or by discussions of strategy or intentions. A number of important factors could cause actual results to differ materially from those projected or suggested in the forward looking statement, including the risk factors described in Point's quarterly report on Form 10-K for the year ended December 31, 2005 and from time to time in Point's periodic and other reports filed with the Securities and Exchange Commission.
MSSI Reports 83% Revenue Increase over Prior Year
Business Wire - April 18, 2006 08:00
VIENNA, Va., Apr 18, 2006 (BUSINESS WIRE) -- MSSI (OTCBB:MSSI), an established provider of medical personnel, technology services and homeland security products to government and commercial clients, is pleased to announce financial results for the year ended December 31, 2005.
For the fiscal year ended December 31, 2005, the company reported revenues of $12,345,585, an increase of 83%, as compared to revenues of approximately $6,734,564 for the fiscal year ended December 31, 2004. The increase in revenues in 2005 was attributable to the acquisition of Nurses Onsite Corp.
Gross profit for the year ended December 31, 2005, was $3,966,372, or 32% of revenues, as compared to gross profit of $1,715,963 or 25% of revenues, for the year ended December 31, 2004.
Additionally, for the year ended December 31, 2005, the company reported operating expenses of $5,385,796 or 44% of revenues, as compared to $3,480,057 or 52% of revenues for the year ended December 31, 2004. The decrease in operating expenses as a percentage of revenues can be attributed to increased efficiencies resulting from the acquisition of Nurses Onsite Corp.
MSSI had a net loss of $1,827,114 for the year ended December 31, 2005, compared to a net loss of $2,111,663 for the year ended December 31, 2004. The decreased loss of $284,549 can be attributed to a focus on higher margin sales.
MSSI's President and CEO, Dr. B.B. Sahay, stated, ''Our record revenue performance in 2005, coupled with our improved bottom line is proof positive that our winning business model is being executed by a great management team." Dr. Sahay continued to say, "With the acquisition of Nurses Onsite Corp., the company continues to grow both organically and through strategic acquisitions that provide us with a robust revenue-generating base. It is our intention to control costs and continue growing the company in the months and years to come."
For all future Medical Staffing Solutions investor relations needs, investors are asked to visit the Medical Staffing Solutions IR Hub at http://www.agoracom.com/IR/MedicalStaffing where they can post questions and receive answers within the same day, or simply review questions and answers posted by other investors. Alternatively, investors are able to e-mail all questions and correspondence to MSSI@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.
About MSSI-TeleScience
PTSC .795/.80
PTSC .76/.77
I didn't see any negative about this news except for the delay of the 10Q .What do you think?
Patriot Scientific Announces Proxy Mailing, Receipt of Casio Licensing Distribution; Extends Time for Filing 10-Q3
Business Wire - April 17, 2006 09:00
CARLSBAD, Calif., Apr 17, 2006 (BUSINESS WIRE) -- Patriot Scientific Corporation (OTCBB: PTSC) today announced that the Company has received the distribution of its share of the proceeds from the previously-disclosed Casio license transaction. No further details of the licensing transaction were announced. To date, Patriot has received in excess of $38 million in distributions as its share of licensing revenues generated by its patent portfolio in slightly more than a year, including licenses with AMD, Intel, Hewlett-Packard, Fujitsu and Casio.
In addition, the Company's proxy statement has been filed, on schedule, with the Securities and Exchange Commission. This statement was mailed to shareholders last week, in advance of the Company's Annual Meeting of Shareholders, to be held on Friday, April 28, 2006 at 10:00 a.m. at the La Costa Resort & Spa, 2100 Costa Del Mar Road in Carlsbad, California.
Patriot Scientific also announced that the Company filed for a five-day extension, as permitted by law, to complete its filing of its 10-Q for 3Q 2006. "This extension was filed to allow our financial team a few days of additional time they needed to adequately analyze appropriate accounting and disclosure of significant revenue from licensing transactions and other matters occurring during the quarter," said Chairman and CEO David H. Pohl. "We anticipate no difficulty with this filing, and fully intend to complete our filing on or before the slightly extended due date."
"We also realize that some shareholders get frustrated when there is a gap for a period of time as to announcements of new license transactions for our patent portfolio," Pohl said. "The Alliacense licensing team which manages our portfolio, which is jointly-owned and marketed as the Moore Microprocessor Patent(TM) (MMP) Portfolio, continues to diligently pursue negotiations with candidate companies. The nature of the process is such that it requires our patience because, as much as we and our shareholders might desire otherwise, the status and progress of negotiations must remain confidential, and license agreements are not consummated according to any regular or predictable schedule," he added. "We remain optimistic about our outlook, and we remain focused on maximizing the long-term value of our business for the benefit of our shareholders," Pohl said.
About Patriot Scientific
I added another 75k @ .71 total 100K .No idea why such a big drop.I was hoping to get back in @ .9 + last week .
I'm back in PTSC.68
GSHF and VRDM at least have news, INSQ is P&D .IMO
Agreed .One green penny is better than many red K ,lol.
Ty MT .
VRDM ,GSHF,INSQ..I'm all out with a nice chunk of profit.
CorpHQ Portfolio Company Safeguard Technology Completes Reverse Merger to Create SGT Ventures
SGT Ventures Becomes First CorpHQ Portfolio Company to Achieve Public Listing
REDONDO BEACH, Calif., April 12 /PRNewswire-FirstCall/ -- CorpHQ, Inc. (OTC: COHQ) announced that its portfolio company Safeguard Technology International, Inc., has successfully merged with SGT Acquisition Company, Inc., a wholly owned subsidiary of publicly-traded SGT Ventures Inc. ('SGT Ventures'). SGT Ventures' common stock trades over-the-counter on the Pink Sheets under the trading symbol 'SGVN.'
(Logo: http://www.newscom.com/cgi-bin/prnh/20050628/LATU103LOGO )
As part of the merger transaction, the Safeguard Technology International, Inc., shareholders will receive shares of SGT Ventures in exchange for their Safeguard Technology shares. Safeguard Technology's current management will take equivalent Board and executive positions in which will continue to operate through its wholly owned subsidiaries, including Moore Protection Inc.
With the completion of this transaction, CorpHQ, Inc., has successfully launched its portfolio company and furthered its business of finding, funding and advising small companies on the path to becoming publicly traded entities. A homegrown CorpHQ portfolio company, Safeguard has grown from concept to public listing, establishing itself as a leading provider of next-generation electronic security systems for the high-end residential market in Southern California.
CorpHQ CEO Steve Crane commented: 'Safeguard began as a concept -- a great idea, a needed service, a good marketing strategy, breakthrough technology and a growing market. By providing strategic direction, operational support and access to capital we helped Safeguard transform that visionary idea into a thriving business and, today, into a publicly listed company with a very bright future. This is a true validation of our ability to drive the growth of emerging companies and a testament to our team's talent and hard work. We are thrilled for SGT Ventures and look forward to sharing in their great success in the future.'
SGT Ventures President Robert Perea said: 'We would like to thank CorpHQ for their intense effort, commitment and vision in shepherding our company through its formative stages. Becoming a standalone public company is a huge accomplishment and we are ecstatic to have grown to this level, but we believe this is only the beginning. We are rapidly increasing market share in a highly lucrative industry and working to expand our reach via a very smart growth-by-acquisition strategy. As a publicly traded company, we are perfectly positioned to maximize the exceptional growth opportunities we see before us.'
The terms of the transaction are contained in CorpHQ's Voluntary Notice of Material Event posted on http://www.pinksheets.com/quote/company_profile.jsp?symbol=COHQ.
About SGT Ventures, Inc.
SGT Ventures, Inc. provides innovative technology-based security solutions for elite-class residential clients. Through its Moore Protection business unit, the company delivers leading edge alarms, digital surveillance systems and third-party alarm and video monitoring to customers who demand and can afford the finest residential security services and systems. Positioned within the $21.9 billion electronic security industry, SGT Ventures' strategy is to grow both organically and through strategic acquisitions of companies that span the landscape of residential security, entertainment and technology. SGT Ventures is the first of CorpHQ's portfolio companies to achieve a public listing. SGT Ventures can be found on the internet at www.sgtvinc.com.
About CorpHQ, Inc.
CorpHQ, Inc. provides money and management to high caliber early stage companies, fast-tracking their growth from startup to profitability. Acting as a business accelerator, CorpHQ works with high potential entrepreneurs and provides both the capital and hands-on leadership needed for long term growth. The company has a track record of building successful businesses and making a profit. Since 2001, it has helped develop seven companies while generating five consecutive years of growth and earnings for shareholders.
CorpHQ can be found on the internet at www.corphq.com. The company voluntarily reports all financial information and material events on www.pinksheets.com.
Forward-Looking Statements
Any statements made in this press release which are not historical facts contain certain forward-looking statements; as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement.
For more information please contact:
CorpHQ, Inc. Investor Relations
310-540-8851 Alan W Silberberg or Gregg Davis
aws@corphq.com or gregg@corphq.com
SOURCE CorpHQ, Inc.
Source: PR Newswire (April 12, 2006 - 11:00 PM EDT)